New potential key pathway in patients with ALL
At the 2022 ASH Conference in December, a study was presented that focuses on uncovering key pathways in leukemic-stromal cells through Leukemia-Derived Extracellular Vesicles (LEV) in patients with acute lymphoblastic leukemia (ALL). MD and PhD Signe Modvig from Rigshospitalet in Denmark discussed the findings of this study in this MEDtalk.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
